Managing overactive bladder in primary care

Abstract

O veractive bladder (OAB) is the term used to describe the symptom complex of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology. 1 HOW COMMON IS OAB?Epidemiological studies from North America have reported a prevalence of OAB in women of 16.9%, increasing with age to 30.9% in those over the age of 65 years. 2 Further data from Europe have shown the overall prevalence in men and women over the age of 40 years to be 16.6%. 3 Frequency was the most commonly reported symptom (85%), while 54% complained of urgency and 36% of urgency incontinence. The European Prospective Investigation into Cancer and Nutrition (EPIC) study, a cross-sectional telephone survey conducted in Canada and four European countries including the UK, utilised the International Continence Society terminology (more specific for the current OAB definition) and found the prevalence of OAB to be 12.8% in women and 10.8% in men.

Mirabegrone versus Solifenacine in Treatment of Overactive Bladder in Female Patients in Zagazig University Hospitals

“…Overactive bladder (OAB) syndrome is a symptom complex defined as urinary urgency, usually accompanied by increased daytime frequency and nocturia, with or without urgency incontinence, in the absence of urinary tract infection or other obvious pathology (1) . Urgency incontinence is present in approximately one-third of OAB cases.…”